NeoImmuneTech, Inc. (KOSDAQ:950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,198.00
+23.00 (1.96%)
Feb 21, 2025, 3:30 PM KST
-25.40%
Market Cap 23.69B
Revenue (ttm) 1.09B
Net Income (ttm) -44.01B
Shares Out 19.77M
EPS (ttm) -445.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 521,058
Average Volume 337,774
Open 1,161.00
Previous Close 1,175.00
Day's Range 1,161.00 - 1,224.00
52-Week Range 999.00 - 2,120.00
Beta 0.81
RSI 56.40
Earnings Date Mar 21, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 82
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.